{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:39:26Z","timestamp":1784025566801,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T00:00:00Z","timestamp":1386288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00066-013-0469-0","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T13:42:33Z","timestamp":1386164553000},"page":"149-157","source":"Crossref","is-referenced-by-count":26,"title":["Preoperative chemoradiation with or without induction oxaliplatin plus 5-fluorouracil in locally advanced rectal cancer","Pr\u00e4operative Strahlenchemotherapie mit oder ohne Induktion von Oxaliplatin plus 5-Fluorouracil beim lokal fortgeschrittenen Rektumkarzinom"],"prefix":"10.1007","volume":"190","author":[{"given":"F.A.","family":"Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.V.","family":"Sole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"del Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mu\u00f1oz-Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Garc\u00eda-Sabrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Garcia-Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Peligros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,6]]},"reference":[{"key":"469_CR1","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926\u20131933","journal-title":"J Clin Oncol"},{"key":"469_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"Gijn","year":"2011","unstructured":"Gijn W van, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575\u2013582","journal-title":"Lancet Oncol"},{"key":"469_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00066-012-0131-2","volume":"188","author":"Guckenberger","year":"2012","unstructured":"Guckenberger M, Saur G, Wehner D et al (2012) Comparison of preoperative short course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Strahlenther Onkol 188:551\u2013557","journal-title":"Strahlenther Onkol"},{"key":"469_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-012-0299-5","volume":"189","author":"Sautter-Bihl","year":"2013","unstructured":"Sautter-Bihl ML, Hohenberger W, Fietkau R et al (2013) Rectal cancer: when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol 189:105\u2013110","journal-title":"Strahlenther Onkol"},{"key":"469_CR5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731\u20131740","journal-title":"N Engl J Med"},{"key":"469_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","volume":"72","author":"Bujko","year":"2004","unstructured":"Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72:15\u201324","journal-title":"Radiother Oncol"},{"key":"469_CR7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","volume":"28","author":"Gerard","year":"2010","unstructured":"Gerard JP, Azria D, Gourgou-Bourgade S et al (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2. J Clin Oncol 28:1638\u20131644","journal-title":"J Clin Oncol"},{"key":"469_CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","volume":"13","author":"R\u00f6del","year":"2012","unstructured":"R\u00f6del C, Liersch T, Becker H et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial. Lancet Oncol 13:679\u2013687","journal-title":"Lancet Oncol"},{"key":"469_CR9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/annonc\/mdl085","volume":"17","author":"Calvo","year":"2006","unstructured":"Calvo FA, Serrano FJ, Diaz-Gonz\u00e1lez JA et al (2006) Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation. Ann Oncol 17:1103\u20131110","journal-title":"Ann Oncol"},{"key":"469_CR10","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(86)92612-7","volume":"2","author":"Quirke","year":"1986","unstructured":"Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection, histopathological study of lateral tumor spread and surgical excision. Lancet 2:996\u2013999","journal-title":"Lancet"},{"key":"469_CR11","unstructured":"American Joint Committee on Cancer (2007) General information on cancer staging and end-results reporting. In: Cancer staging handbook, 7th edn. Springer, Heidelberg, pp\u00a01\u201339"},{"key":"469_CR12","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","volume":"23","author":"Rodel","year":"2005","unstructured":"Rodel C, Martus P, Papadoupolos T et al (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688\u20138696","journal-title":"J Clin Oncol"},{"key":"469_CR13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cncr.11075","volume":"97","author":"Crane","year":"2003","unstructured":"Crane CH, Skibber JM, Feig BW et al (2003) Response to preoperative chemoradiation increase the use of sphincter preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97:517\u2013524","journal-title":"Cancer"},{"key":"469_CR14","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/bjs.4162","volume":"90","author":"Glehen","year":"2003","unstructured":"Glehen O, Chapet O, Adham M et al (2003) Long-term results of the Lyons R90-01 randomized trail of preoperative radiotherapy and delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 90:996\u2013998","journal-title":"Br J Surg"},{"key":"469_CR15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ijrobp.2012.02.006","volume":"84","author":"Jakobsen","year":"2012","unstructured":"Jakobsen A, Ploen J, Vuong T et al (2012) Dose\u2013effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses. Int J Radiat Oncol Biol Phys 84:949\u2013954","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"469_CR16","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2004.08.170","volume":"22","author":"Gerard","year":"2004","unstructured":"Gerard JP, Chapet O, Nemoz C et al (2004) Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial. J Clin Oncol 22:2404\u20132409","journal-title":"J Clin Oncol"},{"key":"469_CR17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.bjc.6602960","volume":"94","author":"Glynne-Jones","year":"2006","unstructured":"Glynne-Jones R, Grainger J, Harrison M et al (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer 94:363\u2013371","journal-title":"Br J Cancer"},{"key":"469_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(09)70381-X","volume":"11","author":"Chua","year":"2010","unstructured":"Chua YJ, Barbachano Y, Cunningham D et al (2010) Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 11:241\u2013248","journal-title":"Lancet Oncol"},{"key":"469_CR19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00066-010-2194-2","volume":"186","author":"R\u00f6del","year":"2010","unstructured":"R\u00f6del C, Arnold D, Becker H et al (2010) Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer: is it time for a randomized phase III trial? Strahlenther Onkol 186:658\u2013664","journal-title":"Strahlenther Onkol"},{"key":"469_CR20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"Fernandez-Martos","year":"2010","unstructured":"Fernandez-Martos C, Pericay C, Aparicio J et al (2010) Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 28:859\u2013865","journal-title":"J Clin Oncol"},{"key":"469_CR21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/annonc\/mdr473","volume":"23","author":"Mar\u00e9chal","year":"2012","unstructured":"Mar\u00e9chal R, Vos B, Polus M et al (2012) Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study. Ann Oncol 23:1525\u20131530","journal-title":"Ann Oncol"},{"key":"469_CR22","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"27","author":"Roh","year":"2009","unstructured":"Roh MS, Colangelo LH, O\u2019Connell MJ et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124\u20135130","journal-title":"J Clin Oncol"},{"key":"469_CR23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.radonc.2012.12.005","volume":"106","author":"Bujko","year":"2013","unstructured":"Bujko K, Richter P, Smith FM et al (2013) Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders: a prospective multicentre study. Radiother Oncol 106:198\u2013205","journal-title":"Radiother Oncol"},{"key":"469_CR24","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/annonc\/mds010","volume":"23","author":"Glynne-Jones","year":"2012","unstructured":"Glynne-Jones R, Anyamene N, Moran B, Harrison M (2012) Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation? Ann Oncol 23:2517\u20132526","journal-title":"Ann Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-013-0469-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-013-0469-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-013-0469-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:31:14Z","timestamp":1558564274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-013-0469-0"}},"subtitle":["Long-term outcome analysis","Analyse der Langzeitergebnisse"],"short-title":[],"issued":{"date-parts":[[2013,12,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s00066-013-0469-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,6]]}}}